Abnova (Taiwan) Corporation (TPE:4133)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.80
-0.25 (-0.92%)
Jul 4, 2025, 1:35 PM CST

Abnova (Taiwan) Company Description

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies.

The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations.

It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies.

In addition, the company provides integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services.

It serves academic, research institutions, and pharmaceutical factories. Abnova (Taiwan) Corporation was founded in 2002 and is headquartered in Taipei, Taiwan.

Abnova (Taiwan) Corporation
Abnova (Taiwan) logo
Country Taiwan
Founded 2002
Industry Biotechnology
Sector Healthcare
CEO Peiru Ji

Contact Details

Address:
No. 108, Jhouzih Street
Taipei, 114
Taiwan
Phone 886 2 8751 1888
Website abnova.com

Stock Details

Ticker Symbol 4133
Exchange Taiwan Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004133004
SIC Code 2836

Key Executives

Name Position
Peiru Ji GM and Director
Yaping Zhang Accounting Supervisor
Yi Huang Huang Deputy General Manager